As per MRFR analysis, the Branched Stent Graft Market Size was estimated at 1.76 (USD Billion) in 2022.The Branched Stent Graft Market Industry is expected to grow from 1.9(USD Billion) in 2023 to 3.8 (USD Billion) by 2032. The Branched Stent Graft Market CAGR (growth rate) is expected to be around 7.98% during the forecast period (2024 - 2032).
Key market drivers in the Branched Stent Graft market include the rising prevalence of aortic aneurysms and dissections, increasing adoption of minimally invasive endovascular procedures, advancements in technology leading to improved device designs, and expanding reimbursement coverage. This market presents significant growth opportunities as patient populations increase and innovative technologies emerge.Notable trends in recent times include the development of next-generation devices with enhanced flexibility, reduced profile, and improved durability. The use of advanced imaging techniques and procedural planning tools is also gaining traction, enabling more precise and efficient interventions. Moreover, the growth of robotic-assisted procedures and the integration of artificial intelligence in stent graft design offer promising avenues for market expansion.Opportunities can be explored in the development of tailored devices for specific anatomical variations, addressing unmet clinical needs. Additionally, the expansion of markets in emerging economies and the increasing awareness of endovascular therapies among patients and healthcare providers present lucrative avenues for market penetration.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Cardiovascular diseases, including heart attacks and strokes, are a major cause of mortality and morbidity worldwide. The increasing prevalence of these diseases is a key driver of the growth of the branched stent graft market. Branched stent grafts are used to treat aortic aneurysms, a condition in which the aorta, the body's largest artery, becomes enlarged and weakened. As the population ages, the incidence of aortic aneurysms is expected to increase, further driving the demand for branched stent grafts. The rising prevalence of cardiovascular diseases is attributed to several factors, including unhealthy lifestyles, such as smoking, unhealthy diet, and lack of physical activity. Additionally, the increasing prevalence of diabetes and obesity contributes to the development of cardiovascular diseases. As a result, the demand for branched stent grafts is expected to increase in the coming years. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths in 2019.The WHO projects that the number of deaths from cardiovascular diseases will continue to rise in the coming years, reaching 23.6 million by 2030. The increasing prevalence of cardiovascular diseases is a major concern for healthcare systems worldwide. Branched stent grafts offer a minimally invasive and effective treatment option for aortic aneurysms, which can help to improve patient outcomes and reduce the burden on healthcare systems.
The Branched Stent Graft Market Industry has witnessed significant technological advancements in recent years. These advancements have led to the development of more effective and less invasive branched stent grafts. For instance, the introduction of self-expanding branched stent grafts has eliminated the need for open surgery, which has reduced patient recovery time and improved outcomes. Additionally, advancements in imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI), have improved the accuracy of stent graft placement.This has led to better patient outcomes and reduced the risk of complications. The continuous development of new and improved branched stent grafts is expected to drive the growth of the market in the coming years. Researchers are exploring the use of new materials and designs to improve the performance and durability of branched stent grafts. These advancements are expected to further expand the applications of branched stent grafts and improve patient outcomes.
Endovascular procedures are less invasive than traditional open surgery and offer several advantages, including reduced recovery time, less pain, and fewer complications. As a result, there has been a growing awareness and acceptance of endovascular procedures among both patients and physicians. Branched stent grafts are an important part of endovascular procedures used to treat aortic aneurysms. The increasing acceptance of endovascular procedures is expected to drive the demand for branched stent grafts in the coming years. To promote awareness and acceptance of endovascular procedures, several initiatives have been undertaken by healthcare organizations and professional societies. These initiatives include educational campaigns, conferences, and workshops. The aim of these initiatives is to educate patients and physicians about the benefits of endovascular procedures and to encourage their use.
The Branched Stent Graft Market segmentation by Device Type can be divided into Aortic Branched Stent Grafts, Iliac Branched Stent Grafts, and Femoral Branched Stent Grafts. Among these, Aortic Branched Stent Grafts held the largest market share in 2023, and is expected to maintain its dominance throughout the forecast period. The growth of this segment can be attributed to the rising prevalence of aortic aneurysms and the increasing adoption of endovascular repair techniques. Iliac Branched Stent Grafts are expected to witness a significant growth rate during the forecast period.This growth can be attributed to the increasing number of minimally invasive procedures being performed for the treatment of iliac artery aneurysms and occlusive diseases. The growth of the market is attributed to the increasing prevalence of aortic aneurysms, iliac artery aneurysms, and peripheral artery disease, as well as the rising adoption of endovascular repair techniques.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
The Branched Stent Graft Market is segmented based on material into Nitinol, Polytetrafluoroethylene (PTFE), and Polyester. In 2023, the Nitinol segment held the largest market share of around 65%, owing to its excellent biocompatibility, flexibility, and strength. It is used in the manufacturing of stents and stent grafts for the treatment of aortic aneurysms and dissections. The PTFE segment is expected to witness significant growth over the forecast period due to its high durability, low friction coefficient, and resistance to kinking.It is commonly used in the production of vascular grafts for peripheral artery disease and hemodialysis access. The Polyester segment is gaining traction in the market as it offers high tensile strength and resistance to tear. It is primarily used in the manufacturing of stent grafts for the treatment of abdominal aortic aneurysms.
The Branched Stent Graft Market is segmented based on endovascular access into Transfemoral, Transradial, and Subclavian. In 2023, the Transfemoral segment accounted for the largest share of the market, owing to its wide acceptance and established techniques. However, the Transradial segment is projected to grow at a higher CAGR during the forecast period, due to its advantages such as reduced bleeding complications and improved patient comfort. The Subclavian segment is expected to witness a steady growth, supported by the increasing adoption of minimally invasive endovascular procedures.
The regional segmentation of the Branched Stent Graft Market presents distinct market dynamics and growth opportunities. North America dominates the market with a significant share, driven by factors such as advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and favorable reimbursement policies. Europe follows closely, with a well-established healthcare system and a large patient population. The Asia-Pacific (APAC) region is expected to witness substantial growth due to rising disposable incomes, increasing healthcare expenditure, and growing awareness about cardiovascular health.South America and the Middle East and Africa (MEA) regions offer emerging markets with untapped potential for market expansion. Overall, the Branched Stent Graft Market is witnessing robust growth, with key players focusing on strategic partnerships, product innovations, and geographical expansion to capitalize on these regional market opportunities. In 2024, the Branched Stent Graft Market revenue is projected to reach USD 2.1 billion, with a CAGR of 8.5% from 2024 to 2032.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Major players in Branched Stent Graft Market industry are focused on developing innovative products and expanding their reach. Leading Branched Stent Graft Market players are investing heavily in research and development to introduce advanced products that meet the evolving needs of patients and healthcare providers. Partnerships and collaborations among industry participants are also driving Branched Stent Graft Market development, enabling the sharing of expertise and resources. The Competitive Landscape of the Branched Stent Graft Market is characterized by intense competition among established players and emerging entrants. Top players are leveraging their strong distribution networks and brand recognition to maintain their market positions, while smaller companies are focusing on niche markets and cost-effective solutions to gain a competitive edge.Medtronic is a leading company in the Branched Stent Graft Market, offering a comprehensive portfolio of branched stent grafts for the treatment of complex aortic aneurysms. The company's Endurant II and Valiant Captivia Stent Grafts are widely recognized for their excellent clinical outcomes and durability. Medtronic's strong presence, established distribution channels, and commitment to innovation have contributed to its leadership position in the market. The company is actively involved in research and development to enhance the performance and functionality of its products, ensuring its continued competitiveness in the face of evolving market dynamics.Boston Scientific is another prominent player in the Branched Stent Graft Market, known for its innovative product offerings and strong market presence. The company's Zenith Alpha and Zenith TX2 Stent Grafts are highly regarded for their advanced features and versatility in treating complex aortic pathologies. Boston Scientific's commitment to clinical research and collaboration with leading medical centers has enabled it to develop differentiated products that meet the specific needs of patients. The company's extensive distribution network and established relationships with healthcare providers have been instrumental in its success in the Branched Stent Graft Market.
Key Companies in the Branched Stent Graft Market Include
Branched Stent Graft Market Industry Developments
The branched stent graft market is anticipated to witness substantial growth in the coming years, driven by factors such as rising prevalence of aortic aneurysms, increasing adoption of minimally invasive procedures, and technological advancements. The market is expected to reach a value of USD 3.8 billion by 2032, expanding at a CAGR of 7.98% from 2024 to 2032.Recent advancements in branched stent grafts include the development of fenestrated and branched endografts, which allow for more precise and effective treatment of complex aortic aneurysms. Key players in the market are focused on research and development to enhance the safety and efficacy of these devices.Notable news developments in the market include the FDA approval of Cook Medical's Zenith AlphaThoracic Stent Graft System in 2023, which is designed for the treatment of complex thoracic aortic aneurysms. Additionally, Medtronic announced the launch of its Valiant Navion thoracic stent graft system in 2024, which features an innovative design to improve conformability and reduce the risk of endoleaks.
| Report Attribute/Metric | Details |
| Market Size 2022 | 1.76(USD Billion) |
| Market Size 2023 | 1.9(USD Billion) |
| Market Size 2032 | 3.8(USD Billion) |
| Compound Annual Growth Rate (CAGR) | 7.98% (2024 - 2032) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2023 |
| Market Forecast Period | 2024 - 2032 |
| Historical Data | 2019 - 2023 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Terumo Aortic, ev3, Microport, L Medical, W. L. Gore Associates, Shenzhen Margin Medical, Boston Scientific, Cook Medical, Stryker, EndoVascular Technologies, Gore Medical, Jotec, Medtronic, A Medical, Convatec |
| Segments Covered | Device Type, Material, Endovascular Access, Regional |
| Key Market Opportunities | Increased prevalence of aortic aneurysms Technological advancements Rising demand for minimally invasive procedures Growing awareness Expanding indications for branched stent grafts |
| Key Market Dynamics | Increased prevalence of aortic aneurysms Technological advancements Rising demand for minimally invasive procedures Growing geriatric population Favorable reimbursement policies |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Branched Stent Graft Market is expected to be valued at USD 1.9 billion in 2023.
The Branched Stent Graft Market is expected to grow at a CAGR of 7.98% from 2024 to 2032.
North America is expected to hold the largest share of the Branched Stent Graft Market in 2023.
The endovascular repair of abdominal aortic aneurysms (AAA) is expected to drive the growth of the Branched Stent Graft Market.
The key competitors in the Branched Stent Graft Market include Medtronic, Cook Medical, Terumo, Jotec, and Bolton Medical.
The Branched Stent Graft Market is expected to be valued at USD 3.8 billion in 2032.
Asia Pacific is expected to grow at the highest CAGR in the Branched Stent Graft Market from 2024 to 2032.
The key factors driving the growth of the Branched Stent Graft Market include the increasing prevalence of aortic aneurysms, the rising adoption of endovascular repair techniques, and the growing demand for minimally invasive procedures.
The challenges faced by the Branched Stent Graft Market include the high cost of branched stent grafts, the risk of complications associated with endovascular repair procedures, and the limited availability of skilled surgeons.
The opportunities for growth in the Branched Stent Graft Market include the development of new and improved branched stent grafts, the expansion of endovascular repair techniques into new markets, and the growing demand for minimally invasive procedures.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
